Author

R. Yamin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

J. V. Ravetch· 3 shared K. S. Kao· 2 shared A. Glasgow· 1 shared A. Gupta· 1 shared A. P. Wiita· 1 shared C. M. Rice· 1 shared D. A. Oren· 1 shared D. Limonta· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

J. V. Ravetch

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mechanism of glycoform specificity and protection against antibody dependent enhancement by an anti-afucosylated IgG nanobody

A. Gupta, K. S. Kao, R. Yamin, D. A. Oren, Y. Golgur, J. Du, P. Lollar, E. Sundberg, J. V. Ravetch

This paper presents the X-ray structure of a nanobody that binds afucosylated IgG1 Fc and disrupts pathogenic interactions, rescuing mice in a dengue model.

bioRxiv · Jan 23, 2023 · PreprintImmunology

Human FcγRIIIa activation on splenic macrophages drives the in vivo pathogenesis of dengue disease

R. Yamin, K. S. Kao, M. R. MacDonald, T. Cantaert, C. M. Rice, J. V. Ravetch, S. Bournazos

This study shows that anti-DENV IgG antibodies drive dengue pathogenesis via FcγRIIIa on splenic macrophages, leading to inflammation and mortality.

bioRxiv · Nov 2, 2022 · PreprintImmunology

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

A. Glasgow, J. E. Glasgow, D. Limonta, P. Solomon, I. Lui, Y. Zhang, M. A. Nix, N. J. Rettko, S. A. Lim, S. Zha, R. Yamin, K. Kao, O. S. Rosenberg, J. V. Ravetch, A. P. Wiita, , J. A. Wells

This paper describes engineered ACE2 receptor traps that potently neutralize SARS-CoV-2 by blocking viral entry through enhanced binding affinity.

bioRxiv · Jul 31, 2020Bioengineering